MPN Panel

A 31 gene panel for work up of PV, ET or PMF.

Test description

This panel combines detection of variants in JAK2, CALR and MPL with additional genes important in the diagnostic workup and prognostication of polycythaemia vera, essential thrombocythaemia and primary myelofibrosis.

Test information

Test name

Myeloproliferative Neoplasm (MPN) Panel

Clinical indication

For diagnostic work-up of a patient with clinical and laboratory evidence of polycytheamia (PV), essential thrombocythaemia (ET) or primary myelofibrosis (PMF). Patients with suspected PMF are deemed eligible for a stem cell transplant by the requesting specialist.

Gene(s)

ASXL1, CALR, CBL, CSF3R, CUX1, DNMT3A, ETNK1, EZH2, FLT3, GATA2, IDH1, IDH2, JAK2, JAK3, KIT, KRAS, MPL, NF1, NRAS, PTPN11, RUNX1, SETBP1, SF3B1, SH2B3, SRSF2, STAG2, STAT5B, TET2, TP53, U2AF1 and ZRSR2

Method

Next generation sequencing

Turn around time

3- 4 weeks

Medicare eligibility

73398 (ET/PV) or73399 (Transplant eligible PMF)

Price

Please call 1800 822 999 for pricing details if patient is not Medicare eligible.

Test request form

Haematology genetics request form preferred. Standard pathology request form accepted.

Sample type

Blood 4mL EDTA tube or Bone Marrow 4mL EDTA tube

Collection type

Blood or bone marrow

Special instructions

Specialist/consultant physician request only